| |
|
|
|
Axovant Sciences Ltd  
|
|
0 (0%) |
|
|
Open: |
|
Pre close: |
|
Target:
|
4.04
|
|
High: |
|
Low: |
|
Resistance:
|
3.45
4.15
|
|
Volume: |
|
Market Cap: |
0M |
Support:
|
2.33
1.94
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.95
 |
MACD |
MACD(12,26):
|
0.08 |
|
MA(20): |
2.95  |
Signal(12,26,9): |
0.09 |
|
MA(100): |
3.11 |
Stochastic Oscillator |
%K(14,3):
|
44.27 |
|
MA(250): |
3.17 |
%D(3): |
49.83 |
|
Average Volume(K) |
3-Month: |
226797
|
52-Week |
High:
|
5.74 |
|
10-Days: |
108042 |
Low: |
1.41 |
|
RSI |
RSI(14):
|
51.06 |
Change(%): |
-34.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.776 |
Return on Equity (ttm) |
-120.9 |
Shares Out. (M) |
41.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-37.3 |
Shares Float (M) |
19.57 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
39.57 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
24.27 |
|
Forward EPS |
-8.020 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1920 |
|
Book Value (p.s.) |
1.430 |
EBITDA (p.s.) |
-1.189 |
P/E |
-1.63 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.02 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-63.24 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-40.86 |
P/CF |
-1.92 |
|
|
|
|
|
|
